BioCentury
ARTICLE | Finance

General departure

Why buysiders think last week's sell-off is a healthy sign

May 4, 2015 7:00 AM UTC

Buysiders contacted by BioCentury agree last week's 6% hosing of biotech indices reflects generalist investors exiting the sector. They also expect the companies hardest hit will be early stage biotechs that have seen significant stock rises in recent months.

There's less consensus on whether biotech's convergence with the broader markets is temporary, and how low biotech can go...